Clinuvel Pharmaceuticals Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clinuvel Pharmaceuticals Limited with three other
companies in this sector in Australia:
sales of 18.61 million Australian Dollars [US$14.81 million]
of which 88%
was Drug discovery and development),
Xrf Scientific Ltd
(21.54 million Australian Dollars [US$17.15 million]
of which 40%
was Precious Metals), and
(17.64 million Australian Dollars [US$14.04 million]
of which 77%
was Bronchitol and Aridol).
During the year ended June of 2017, sales at
Clinuvel Pharmaceuticals Limited were A$17.03 million (US$13.56 million).
increase of 142.3%
versus 2016, when the company's sales were A$7.03 million.
This was the fifth consecutive year of sales increases at Clinuvel Pharmaceuticals Limited
(and since 2012, sales have increased a total of 1,216%).